Iris Nagelmeier
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 9
- Colorectal Cancer Treatments and Studies 4
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Josef Rüschoff (10 shared papers)W. Schlake (3 shared papers)Gustavo Baretton (3 shared papers)Heinz Höfler (3 shared papers)Hans Kreipe (3 shared papers)Manfred Dietel (3 shared papers)Susanne Arbogast (1 shared paper)Marie‐Pierre Chenard (1 shared paper)
- Journals
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (2 papers)Journal of Clinical Pathology (1 paper)Neoplasia (1 paper)Modern Pathology (1 paper)Oncotarget (1 paper)
- Partner nations
- GermanyItalyUnited States
In The Last Decade
Iris Nagelmeier
12 papers receiving 638 citations
Peers
Comparison fields: 5 of 47
- Oncology 525
- Pulmonary and Respiratory Medicine 366
- Gastroenterology 54
- Radiology, Nuclear Medicine and Imaging 224
- Cancer Research 102
Countries citing papers authored by Iris Nagelmeier
This map shows the geographic impact of Iris Nagelmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Nagelmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Nagelmeier more than expected).
Fields of papers citing papers by Iris Nagelmeier
This network shows the impact of papers produced by Iris Nagelmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Nagelmeier. The network helps show where Iris Nagelmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Nagelmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 368 | |
| 2 | 2009 | 96 | |
| 3 | 2022 | 46 | |
| 4 | 2015 | 42 | |
| 5 | 2010 | 33 | |
| 6 | 2015 | 21 | |
| 7 | 2012 | 18 | |
| 8 | 2009 | 13 | |
| 9 | 2020 | 5 | |
| 10 | 2007 | 4 | |
| 11 | 2009 | 3 | |
| 12 | Her2-Diagnostik beim Magenkarzinom: Was ist anders im Vergleich zum Mammakarzinom? | 2010 | 1 |
About Iris Nagelmeier
Iris Nagelmeier is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Molecular Biology and Neurology, having authored 12 papers that have together received 650 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (4 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (1 paper), Breast Cancer Treatment Studies (1 paper) and Vascular Malformations Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (525 citations), Pulmonary and Respiratory Medicine (366 citations), Gastroenterology (54 citations), Radiology, Nuclear Medicine and Imaging (224 citations) and Cancer Research (102 citations). Iris Nagelmeier has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Josef Rüschoff, W. Schlake, Gustavo Baretton, Heinz Höfler, Hans Kreipe, Manfred Dietel, Susanne Arbogast, Marie‐Pierre Chenard, Frédérique Penault‐Llorca and Axel Walch. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Journal of Clinical Pathology, Neoplasia, Modern Pathology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.